This document provides guidance on the conduct of clinical studies for solid organ transplantation. It definines treatment goals, study designs, outcome measures and data analysis for new immunosuppressive products developed to prevent and treat solid organ allograft rejection.

Keywords: Immunosuppressants, solid organ transplantation

Current effective version

Document history

Share this page